Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 76.74% is 60% below its 3-year average of 193.65%, near the low end of its 3-year range (1.88%–665.41%).
As of the fiscal period ended Tuesday, June 30, 2026. 24.77% above its 12-month average of 61.50%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 76.74%.
DEBT TO ASSETS RATIO
76.74%
DEBT TO ASSETS RATIO AVG TTM
61.50%
DEBT TO ASSETS RATIO AVG 3Y
214.63%
DEBT TO ASSETS RATIO AVG 5Y
N/A
DEBT TO ASSETS RATIO AVG 10Y
N/A
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+24.77%
CURRENT VS 3Y AVG
-64.25%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.11%
median of 462 covered companies
CURRENT VS SECTOR MEDIAN
+69659.39%
vs the sector median at left
Adagio Medical Holdings, Inc.
Market Cap
$3.13M
Debt to Assets Ratio
76.74%
TTM Avg
61.50%
3Y Avg
214.63%
5Y Avg
N/A
Market Cap
$3.09M
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.37M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.44M
Debt to Assets Ratio
0.06%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.59M
Debt to Assets Ratio
0.19%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.47M
Debt to Assets Ratio
0.18%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Adagio Medical Holdings, Inc. (ADGM) | $3.13M | 76.74% | 61.50% | 214.63% | N/A |
| BioRestorative Therapies, Inc. (BRTX)vs › | $3.09M | 0.01% | N/A | N/A | N/A |
| Cadrenal Therapeutics, Inc. Common Stock (CVKD)vs › | $3.37M | 0.00% | N/A | N/A | N/A |
| Aethlon Medical, Inc. (AEMD)vs › | $3.44M | 0.06% | N/A | N/A | N/A |
| IceCure Medical Ltd (ICCM)vs › | $3.47M | 0.01% | N/A | N/A | N/A |
| Evogene Ltd. (EVGN)vs › | $3.48M | 0.16% | N/A | N/A | N/A |
| Eocene Ltd. (EOCN)vs › | $3.59M | N/A | N/A | N/A | N/A |
| bioAffinity Technologies, Inc. (BIAF)vs › | $2.59M | 0.19% | N/A | N/A | N/A |
| FibroBiologics, Inc. Common Stock (FBLG)vs › | $2.47M | 0.18% | N/A | N/A | N/A |
| Creative Medical Technology Holdings, Inc. (CELZ)vs › | $2.37M | 0.00% | N/A | N/A | N/A |
Debt/Assets
76.7%
Debt/Equity
N/A
Current Ratio
1.41
Interest Coverage
-7.5x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 76.74% |
| 2026-03-31 | 61.28% |
| 2025-12-31 | 50.30% |
| 2025-09-30 | 69.63% |
| 2025-06-30 | 49.56% |
| 2025-03-31 | 44.95% |
| 2024-12-31 | 33.57% |
| 2024-09-30 | 13.04% |
| 2024-06-30 | 646.99% |
| 2024-03-31 | 512.86% |
| 2023-12-31 | 562.62% |
| 2023-09-30 | 665.41% |
| 2023-06-30 | 3.23% |
| 2023-03-31 | 1.88% |
| 2022-12-31 | 112.65% |
